Cargando…
sTREM-1 and TNF-α levels are associated with the clinical outcome of leprosy patients
Leprosy reaction (LR) and physical disability (PD) are the most significant clinical complications of leprosy. Herein, we assessed the circulating serum-sTREM-1 and TNF-α levels and their genetic polymorphisms in leprosy. Serum-sTREM-1 and TNF-α levels were measured in leprosy patients (LP) before t...
Autores principales: | Bezerra-Santos, Márcio, Bomfim, Lays G. Santos, Santos, Camilla N. Oliveira, Cunha, Maria Wiliane N., de Moraes, Eduardo J. Rocha, Cazzaniga, Rodrigo A., Tenório, Martha D. L., Araujo, Jonnia M. Sherlock, Menezes-Silva, Lucas, Magalhães, Lucas Sousa, Barreto, Aline S., Reed, Steven G., Duthie, Malcolm S., Lipscomb, Michael W., de Almeida, Roque Pacheco, de Moura, Tatiana Rodrigues, de Jesus, Amélia Ribeiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339318/ https://www.ncbi.nlm.nih.gov/pubmed/37457576 http://dx.doi.org/10.3389/fmed.2023.1177375 |
Ejemplares similares
-
Leishmania infantum Induces the Release of sTREM-1 in Visceral Leishmaniasis
por: Bomfim, Lays G. S., et al.
Publicado: (2017) -
Influence of Testosterone in Neglected Tropical Diseases: Clinical Aspects in Leprosy and In Vitro Experiments in Leishmaniasis
por: de Oliveira Rekowsky, Laís Lima, et al.
Publicado: (2023) -
Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and other inflammatory mediators in malaria by Plasmodium vivax during enteroparasites coinfection
por: de Jesus, Myrela Conceição Santos, et al.
Publicado: (2022) -
TREM-1 Expression on the Surface of Neutrophils in Patients With Visceral Leishmaniasis Is Associated With Immunopathogenesis
por: Bomfim, Lays Gisele Santos, et al.
Publicado: (2022) -
Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease
por: Hok-A-Hin, Yanaika S., et al.
Publicado: (2023)